FDA Inspection
Mipharm S.p.A.Mipharm S.p.A. – FDA Inspection, Feb 3, 2017
Record Details
This FDA Inspection record concerns Mipharm S.p.A., with an inspection on February 3, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
- People
- Jose E. Melendez (FDA Associated Person)
- Rosa J. Motta (Issuing Officer)
View Company Profile
ID · 6079ccf1-30c3-4af0-b5a6-e75d46f17ad5
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1004998
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Mipharm S.p.A.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| September 22, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 17, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 14, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 27, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 10, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Mipharm S.p.A.
- FDA Inspection 1219480 - 2023-09-22
- FDA Inspection 1133100 - 2019-10-17
- FDA Inspection 870680 - 2014-02-14
- FDA Inspection 853837 - 2013-09-27
- FDA Inspection 731940 - 2011-06-10
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.